PharmaShots | Incisive News in 3 Shots

Subscribe Now

Longboard Pharmaceuticals

Longboard Pharmaceuticals Reports Results for Bexicaserin (LP352) in P-Ib/IIa Trial for Developmental and Epileptic Encephalopathies (DEEs)

Longboard Pharmaceuticals Reports Results for Bexicaserin (LP352) in P-Ib/IIa Trial for Developmental and Epileptic Encephalopathi...

January 3, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us